W1M Asset Management Ltd bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 816,669 shares of the semiconductor company’s stock, valued at approximately $364,116,000. Synopsys comprises about 3.3% of W1M Asset Management Ltd’s portfolio, making the stock its 13th biggest holding.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Sankala Group LLC acquired a new position in Synopsys in the 4th quarter valued at $25,000. Elevation Wealth Partners LLC boosted its stake in Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the last quarter. IMG Wealth Management Inc. purchased a new stake in shares of Synopsys during the second quarter worth $28,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Synopsys during the fourth quarter worth $28,000. Finally, Atlas Capital Advisors Inc. acquired a new stake in shares of Synopsys in the fourth quarter valued at about $32,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on SNPS shares. Benchmark reissued a “buy” rating on shares of Synopsys in a research note on Wednesday. Citigroup raised their target price on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Berenberg Bank set a $633.00 target price on Synopsys in a report on Wednesday, May 27th. Stifel Nicolaus upped their price target on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $563.59.
Synopsys Trading Down 0.0%
SNPS opened at $397.87 on Friday. The stock has a market capitalization of $76.18 billion, a PE ratio of 92.10, a P/E/G ratio of 2.34 and a beta of 1.23. Synopsys, Inc. has a one year low of $366.00 and a one year high of $615.79. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The business’s 50 day moving average price is $419.73 and its 200 day moving average price is $440.22.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. Synopsys’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities research analysts expect that Synopsys, Inc. will post 10.64 EPS for the current year.
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
